Research update – ProQR
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Search results
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Make double the difference with The Big Give Christmas Challenge.
Raise money to help support people affected by inherited sight loss to lead better lives today and accelerate the search for treatments for the future.
At Retina UK we get many queries from those overseas affected by inherited retinal dystrophies (IRDs). Understandably, many want to know about research and how they can get involved. Retina UK does not organise trials or directly recruit participants.
Experience the thrill of the Green Park Reading Half Marathon, one of the UK’s most celebrated half marathons since its launch in 1983 and support Retina UK in 2026.
Many inherited sight loss conditions occur when cells in the retina, which is the light-sensitive region at the back of the eye, deteriorate in an unpredictable way. These conditions are often referred to as inherited retinal dystrophies.
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2027.
The Great North Run is the largest half marathon in the world, taking place annually in Newcastle.
Lockdown may have put the brakes on Euroglaze’s fundraising campaign for Retina UK initially, but the team at the Barnsley based Rehau fabricator are now on a roll once again.
Researchers in the Netherlands are developing a “retina-on-a-chip” that mimics the key layers of the human retina, offering a powerful new way to study inherited retinal diseases (IRDs) and test potential treatments using human cells.